Get all the most recent information on coronavirus and extra delivered each day to your inbox. Join right here.
Presently, there isn’t a recognized scientific treatment for the illness often called COVID-19, however researchers at a New York Metropolis hospital system are testing a compound present in heartburn medicine to see if it may be used as remedy.
Northwell Well being is trialing the compound famotidine, which is discovered within the heartburn drug Pepcid, in additional than 150 sufferers to see if it inhibits the coronavirus, in a similar way that sure medication block HIV/AIDS replication.
Talking with Science Magazine, which first reported the information, Kevin Tracey, a former neurosurgeon answerable for Northwell Well being’s analysis stated that he saved the information of the trial below wraps, for worry of a run on the provision. This occurred with lupus sufferers and hydroxychloroquine earlier this month, Fox Information beforehand reported.
CLINICAL TRIAL OF POTENTIAL CORONAVIRUS TREATMENT HYDROXYCHLOROQUINE BEGINS, NIH SAYS
“If we talked about this to the flawed individuals or too quickly, the drug provide can be gone,” Tracey instructed the information outlet.
He added that he would preserve outcomes of the trial’s prospects till the preliminary outcomes from the primary 391 sufferers (they hope to have practically 1,200 sufferers) have been tallied. “If it does work, we’ll know in just a few weeks,” he defined.
In response to the New York Put up, Northwell’s North Shore College Hospital, Lengthy Island Jewish Medical Middle and Lenox Hill Hospital are taking part within the examine.
Fox Information has reached out to a Northwell Well being with a request for remark for this story.
The trial is combining famotidine together with hydroxychloroquine, an anti-malarial drug first used within the 1950s. Final week, the FDA warned the drug, which President Trump has touted as a possible “game-changer,” ought to be averted exterior of hospitals, following stories of “severe coronary heart rhythm issues.”
AMAZON FIRES MORE EMPLOYEES WHO CRITICIZED WAREHOUSE CONDITIONS DURING CORONAVIRUS PANDEMIC
The group taking famotidine will probably be in contrast with a bunch taking solely hydroxychloroquine, in addition to a management group.
A current examine carried out at U.S. veterans hospitals confirmed the drug offered no profit to COVID-19 sufferers. Nevertheless, the examine cohort comprised solely males whose median age was over 65 years. The VA instructed Fox Information that the analysis findings shouldn’t be seen as definitive, noting that it was not a scientific trial.
CLICK HERE FOR COMPLETE CORONAVIRUS COVERAGE
As of Monday morning, practically three million coronavirus instances have been identified worldwide, greater than 965,000 of that are within the U.S., essentially the most impacted nation on the planet.
GET THE FOX NEWS APP
Fox Information’ Madeline Farber and James Rogers contributed to this story.